Biotech. Stocks: Questcor Pharmaceuticals, Ariad Pharmaceuticals, Sangamo Biosciences, Vanda Pharmaceuticals Inc

Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Questcor Pharmaceuticals, Inc.(NASDAQ:QCOR) lost 1.21% and closed at $32.60. Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company’s primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration, for the treatment of 19 indications.

How Should Investors Trade QCOR After The Recent Movement? Find Out Here

Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) is higher 0.77% and closed at $21.03. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.

Is ARIA Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Sangamo Biosciences, Inc.(NASDAQ:SGMO) added 9.45% and closed at $10.19. Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc finger deoxyribonucleic acid (DNA)-binding proteins (ZFPs), a naturally occurring class of proteins.

Is SGMO a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Vanda Pharmaceuticals Inc.(NASDAQ:VNDA) lost 1.83% and closed at $3.76. Vanda Pharmaceuticals Inc. (Vanda), is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. The Company’s products include Fanapt a compound for the treatment of schizophrenia andTasimelteon is a compound for the treatment of sleep and mood disorders, including Circadian Rhythm Sleep Disorders (CRSD).

How Should Investors Trade VNDA After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.